Targeted Mobilisation of Endogenous Endothelial Progenitor Cells - an Alternate Approach to Allogeneic Therapy for Ischaemic Cardiovasular Disease?
Cardiovasc Drugs Ther
.
2023 Oct;37(5):839-841.
doi: 10.1007/s10557-023-07462-z.
Epub 2023 May 3.
Authors
Karla M O'Neill
1
,
David J Grieve
2
Affiliations
1
Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, BT9 7AE, UK.
2
Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, BT9 7AE, UK. d.grieve@qub.ac.uk.
PMID:
37133551
DOI:
10.1007/s10557-023-07462-z
No abstract available
Publication types
Editorial
MeSH terms
Endothelial Progenitor Cells*
Hematopoietic Stem Cell Transplantation*
Grants and funding
PG/14/78/31099/BHF_/British Heart Foundation/United Kingdom
PG/19/61/34586/BHF_/British Heart Foundation/United Kingdom
PG/21/10689/BHF_/British Heart Foundation/United Kingdom